A Fully Human Inhibitory Monoclonal Antibody to the Wnt Receptor RYK

• Michael M. Halford ,

  Contributed equally to this work with: Michael M. Halford, Maria L. Macheda

  Affiliations Tumour Angiogenesis Program, Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia, Angiogenesis Laboratory, Ludwig Institute for Cancer Research, Royal Melbourne Hospital, Parkville, Victoria, Australia

  ⨯
• Maria L. Macheda ,

  Contributed equally to this work with: Michael M. Halford, Maria L. Macheda

  Affiliations Tumour Angiogenesis Program, Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia, Angiogenesis Laboratory, Ludwig Institute for Cancer Research, Royal Melbourne Hospital, Parkville, Victoria, Australia

  ⨯
• Clare L. Parish,

  Affiliation Florey Neuroscience Institutes, Melbourne Brain Centre, The University of Melbourne, Parkville, Victoria, Australia

  ⨯
• Elena A. Takano,

  Affiliation Tumour Angiogenesis Program, Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia

  ⨯
• Stephen Fox,

  Affiliations Tumour Angiogenesis Program, Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia, Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, Victoria, Australia

  ⨯
• Daniel Layton,

  Affiliation Monash Antibody Technologies Facility, Monash University, Clayton, Victoria, Australia

  ⨯
• Edouard Nice,

  Affiliation Monash Antibody Technologies Facility, Monash University, Clayton, Victoria, Australia

  ⨯
• Steven A. Stacker

  * E-mail: Steven.Stacker@petermac.org

  Affiliations Tumour Angiogenesis Program, Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia, Angiogenesis Laboratory, Ludwig Institute for Cancer Research, Royal Melbourne Hospital, Parkville, Victoria, Australia, Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, Victoria, Australia

  ⨯